IFNA5 - interferon alpha 5 Gene
Also Known as INA5; INFA5; leIF G; IFN-alphaG; IFN-alpha-5
生物種: Homo sapiens
遺伝子タイプ: protein coding
遺伝子ID: 3442
About IFNA5
Cytogenetic location: 9p21.3
Genomic coordinates (GRCh38): 9:21,304,326-21,305,313 (from NCBI)
This gene has 1 transcript (splice variant), 579 orthologues and 16 paralogues.
Summary
Predicted to enable cytokine activity and type I interferon receptor binding activity. Predicted to be involved in several processes, including B cell activation; lymphocyte activation involved in immune response; and positive regulation of peptidyl-serine phosphorylation of STAT protein. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
IFNA5 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_002169.3 | NP_002160.1 | interferon alpha-5 precursor |
IFNA5 Protein Structure
Interferon
Interferon: Interferon alpha/beta domain (26 - 187)
- 0
- 100
- 189 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
interferon alpha-5 |
|
Recombinant IFNA5 Proteins
| 製品番号 | 製品名 | アクセッション番号 | 純度 |
|---|---|---|---|
| HY-P75892 | IFN-alpha 5/IFNA5 Protein, Human (HEK293, Fc) | P01569/NP_002160.1 (L22-E189) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P75893 | IFN-alpha 5/IFNA5 Protein, Human (P.pastoris, His) | P01569/NP_002160.1 (L22-E189) | ≥ 90%, as determined by reducing SDS-PAGE. |
関連疾患
| Diseases | Alias | |
|---|---|---|
| Hemangioma Of Lung |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(2)
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS06576 | IFNA5 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18667 | Ifna5 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service